US Patent 7820164 Chimeric, human and humanized anti-CSAP monoclonal antibodies
Patent 7820164 was granted and assigned to IMMUNOMEDICS, INC. on October, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+227 characters)
Article
Patent abstract
The present invention provides humanized, chimeric and human anti-CSAp antibodies and anti-CSAp antibody fusion proteins that are useful for the treatment and diagnosis of various cancers, including colon cancer.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07820164 Chimeric, human and humanized anti-CSAP monoclonal antibodies US Patent 7820164 Chimeric, human and humanized anti-CSAP monoclonal antibodies
Infobox
Patent Number
0782016400
Patent Number
782016400
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078201640
Date of Patent
October 26, 2010
0Patent Application Number
126860110
Date Filed
January 12, 2010
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078201640
Date of Patent
October 26, 2010
0Patent Application Number
126860110
Date Filed
January 12, 2010
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07820164 Chimeric, human and humanized anti-CSAP monoclonal antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07820164
Date of patent
October 26, 2010
Patent application number
12686011
Date Filed
January 12, 2010
Patent primary examiner
Find more entities like US Patent 7820164 Chimeric, human and humanized anti-CSAP monoclonal antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
